Healthcare: Who Had the Better Quarter, Gilead Sciences or Amgen?
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 15 May 2019
⏱️ 25 minutes
🧾️ Download transcript
Summary
It's a battle of the big bio's on this episode of Industry Focus Healthcare. Is Gilead Sciences finally overcoming its hep C headwind? Is Amgen beating back biosimilars? We dig into the details as we discuss which of these biopharma behemoths delivered better first quarter results. Stocks: GILD, AMGN
Check out more of our content here:
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Industry Focus, the show that dives into a different sector of the stock market every single day. |
| 0:08.0 | Today is Wednesday, May the 15th, and we're talking health care. |
| 0:12.0 | I'm your host Shannon Jones Jones and I am joined via Skype |
| 0:14.6 | by health care guru Todd Campbell. Todd how are you doing? I'm doing great |
| 0:19.5 | Shannon. Thanks for having me back on. Before we dive into the meat of the matter, |
| 0:23.8 | I just want to give a quick shout out |
| 0:25.3 | to the inaugural class of students |
| 0:28.0 | at the University of New Hampshire |
| 0:29.2 | who suffered through the entire semester |
| 0:32.0 | with me learning how to talk stocks. |
| 0:34.4 | It was a great experience. |
| 0:35.8 | I think that we've got some future fantastic foolish investors |
| 0:40.1 | coming out of that course. |
| 0:41.3 | Yeah, and that's so exciting. |
| 0:42.7 | I mean, it's awesome to have the opportunity |
| 0:45.4 | to sit under the tutelage of Todd Campbell. |
| 0:47.5 | I can say that because I learned so much every single week |
| 0:50.4 | every time we do the show from you, Todd. |
| 0:52.0 | So, awesome job to you and to them for going |
| 0:55.6 | through the course and hope to see a lot of these newer fools on our |
| 0:58.8 | community discussion boards would love to to start picking brains too, but I'm excited for this week's show, Todd. |
| 1:06.8 | We're continuing on in our series and specifically our series on earnings. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

